5% STAKE4588.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Oncolys BioPharma to 7.93%

Stake history

6%8%10%12%14%16%18%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX11.97%Aug 14Aug 14: 11.97% · S100U7QJ11.05%Aug 21Aug 21: 11.05% · S100U9259.94%Sep 20Sep 20: 9.94% · S100UDNA7.93%Oct 18Oct 18: 7.93% · S100UJHL
6%8%10%12%14%16%18%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX11.97%Aug 14Aug 14: 11.97% · S100U7QJ11.05%Aug 21Aug 21: 11.05% · S100U9259.94%Sep 20Sep 20: 9.94% · S100UDNA7.93%Oct 18Oct 18: 7.93% · S100UJHL

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-10-18 15:21 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 7.93%, previous report: 9.94%.

Open the price chart on TradingView.

Source: EDINET S100UJHL ↗ · PDL1.0 · Not investment advice